Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
12-[[[(2R)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-OXO-2-pyrrolidinyl]carbonyl]amino]- N,N,6-trimethyl-4-pyridinecarboxamide,dihydrochloride----2件: 6, 162 💬
2A single blood sample FOR HLA typing----3件: 35, 38, 162 💬
3AC-203 1% topical ointment----1件: 162 💬
4Adalimumab injection1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬5件: 38, 40, 46, 96, 162 💬
5AKST4290----2件: 6, 162 💬
6Allogeneic adipose tissue-derived mesenchymal stem cells expanded----3件: 38, 96, 162 💬
7Allogenic mesenchymal stem cell isolated from adipose tissue----3件: 38, 96, 162 💬
8Apremilast1件: Apremilast1件: Apremilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬7件: 46, 50, 56, 97, 107, 162, 271 💬
9Arava1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬4件: 46, 53, 54, 162 💬
10Avdoralimab1件: Avdoralimab---1件: 162 💬
11Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--22件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
12Azathioprine or mycophenolate mofetil1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--1件: 162 💬
13Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
14Benralizumab1件: Benralizumab1件: Benralizumab 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬
15Bertilimumab1件: Bertilimumab---2件: 97, 162 💬
16BIV009----2件: 61, 162 💬
17Blood sample and cotton skin swabs----1件: 162 💬
18Blood sampling----9件: 13, 17, 46, 49, 51, 96, 98, 106, 162 💬
19Bone densitometry----2件: 49, 162 💬
20Carboxymethylcellulose1件: Carboxymethylcellulose2件: Carboxymethylcellulose sodium ,
Carmellose 💬 		--2件: 35, 162 💬
21CC-10004----5件: 46, 56, 97, 162, 271 💬
22Cellcept® IN autoimmune bullous dermatoses----2件: 35, 162 💬
23Cellulose acetate with petrolatum1件: Microcrystalline cellulose2件: Microcrystalline cellulose ,
Rayon, purified 💬 		--2件: 35, 162 💬
24Clobetasol 0.05% topical ointment1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
25Clobetasol decreasing measurement1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
26Clobetasol propionate2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 46, 162 💬
27Clobetasol propionate + methotrexate2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
28Clobetasol propionate alone2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
29Clobetasol propionate cream treatment2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
30Clobetasolo propionato----1件: 162 💬
31Collagenase1件: Collagenase clostridium histolyticum1件: Collagenase clostridium histolyticum 💬 --1件: 162 💬
32Cortancyl 20 MG1件: Prednisone acetate1件: Prednisone acetate 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
33Cotton gauze with petrolatum1件: Cotton---2件: 35, 162 💬
34Cultivated oral mucosal epithelial sheet transplantation----2件: 38, 162 💬
35Cutaneous biopsy----1件: 162 💬
36Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
37Cyclophosphamide 50MG oral tablet1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 162 💬
38Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
39Dacortin----2件: 97, 162 💬
40Dapsone1件: Dapsone1件: Dapsone 💬 --5件: 35, 42, 60, 84, 162 💬
41Data report----1件: 162 💬
42Dermoval----2件: 35, 162 💬
43Dexamethasone 0.5MG/5ML solution1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
44DF2156A----1件: 162 💬
45Double dose----2件: 38, 162 💬
46Doxycycline1件: Doxycycline5件: Doxycycline ,
Doxycycline hyclate ,
Doxycycline calcium ,
Doxycycline ,
Doxycycline hydrochloride 💬 		--13件: 23, 28, 34, 46, 84, 89, 96, 97, 158, 161, 162, 280, 299 💬
47Dupilumab1件: Dupilumab1件: Dupilumab 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬5件: 51, 97, 98, 160, 162 💬
48Dupixent1件: Dupilumab1件: Dupilumab 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬3件: 98, 160, 162 💬
49Efgartigimod alfa1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --6件: 11, 14, 35, 53, 63, 162 💬
50Efgartigimod PH20 SC----5件: 11, 14, 35, 63, 162 💬
51Endoxan----6件: 13, 28, 49, 51, 85, 162 💬
52Fasenra1件: Benralizumab1件: Benralizumab 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬
53Galen----1件: 162 💬
54Halometasone1件: Halometasone1件: Halometasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
55Imatinib1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬8件: 34, 35, 46, 51, 85, 86, 87, 162 💬
56Impedance analysis----1件: 162 💬
57Interleukin 2----11件: 35, 46, 49, 51, 56, 63, 95, 96, 97, 162, 271 💬
58Interleukin-21件: Human interleukin-2---9件: 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
59IPH5401----1件: 162 💬
60Ixekizumab1件: Ixekizumab1件: Ixekizumab 💬 1件: IL17A 💬 6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
61Janus kinase inhibitor----4件: 46, 97, 110, 162 💬
62Ladarixin1件: Ladarixin---1件: 162 💬
63Large dose OF prednisolone plus intra-lesional OF triamcinolone acetonide followed THE systemic combination OF mycophenolate mofetil (MMF), dapsone and LOW dose prednisolone IN treatment OF MMP----1件: 162 💬
64Leflunomide1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬13件: 11, 40, 46, 49, 53, 54, 66, 107, 162, 224, 270, 271, 300 💬
65Liquid bubble sampling----1件: 162 💬
66Mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬17件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
67MabthéRA----3件: 35, 63, 162 💬
68MathéRA----2件: 35, 162 💬
69MEDI-563----5件: 44, 45, 98, 162, 299 💬
70Mepolizumab1件: Mepolizumab1件: Mepolizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬4件: 44, 45, 98, 162 💬
71Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
72Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
73Minocycline1件: Minocycline2件: Minocycline hydrochloride ,
Minocycline 💬 		--14件: 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
74Mitomycin1件: Mitomycin1件: Mitomycin 💬 --2件: 162, 329 💬
75Mometasone furoate2件: Mometasone,
Mometasone furoate		3件: Mometasone furoate ,
Mometasone furoate hydrate ,
Mometasone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162 💬
76MTX----14件: 13, 35, 40, 46, 49, 50, 51, 54, 55, 60, 84, 96, 107, 162 💬
77Mycophenolate1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬4件: 43, 84, 162, 228 💬
78Myfortic 180 MG filmtabletten----1件: 162 💬
79Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --5件: 6, 18, 49, 107, 162 💬
80NNC0215-0384----2件: 46, 162 💬
81Nomacopan1件: Nomacopan1件: Nomacopan 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 162 💬
82NPB-01----3件: 13, 14, 162 💬
83Omalizumab1件: Omalizumab1件: Omalizumab 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
84Otezla1件: Apremilast1件: Apremilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 56, 107, 162 💬
85Ozonated olive OIL----2件: 35, 162 💬
86Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
87Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
88Prednisone acetate2件: Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬6件: 35, 46, 49, 63, 162, 222 💬
89QGE031----1件: 162 💬
90Radiographs OF THE thoracic and lumbar spine----1件: 162 💬
91RAY121----2件: 50, 162 💬
92Restasis1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 53, 162 💬
93Riboflavin1件: Riboflavin1件: Riboflavin 💬 --7件: 13, 38, 46, 97, 162, 168, 265 💬
94Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
95Rituximab 1G IV1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
96Rituximab combined with omalizumab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
97RVA576----3件: 62, 109, 162 💬
98Silver1件: Silver---2件: 35, 162 💬
99Simvastatin-ratiopharm1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 162 💬
100Single dose----2件: 38, 162 💬
101SOLU-medrone----3件: 51, 83, 162 💬
102Tildrakizumab prefilled syringe1件: Tildrakizumab1件: Tildrakizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 162 💬
103Tofacitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
104Topical garamycin cream----2件: 35, 162 💬
105Topical infliximab----3件: 38, 39, 162 💬
106Treatment with topical superpotent corticosteroid therapy----1件: 162 💬
107Tripterygium1件: Tripterygium wilfordii whole---4件: 66, 162, 224, 271 💬
108Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬